Article

Sonographic findings of additional malignant lesions in breast carcinoma seen by second look ultrasound.

Department of Radiology, Alcorcon University Hospital Foundation, Madrid, Spain.
Journal of clinical imaging science 01/2011; 1:34. DOI:10.4103/2156-7514.82338 pp.34
Source: PubMed

ABSTRACT The aim is to show ultrasound (US) findings of additional malignant lesions of breast carcinoma visualized on targeted second-look US that were not identified by mammography or US prior to the time of diagnosis.
A double-blind retrospective review of the US results from January 2008 through August 2010 of 228 patients with known breast cancer was conducted by two expert radiologists. The focus of the review was on the second-look US characteristics (following BI-RADS criteria) of 26 documented additional malignant lesions of the 76 with successful sonographic correlation from the 123 lesions detected by magnetic resonance imaging (MRI). All of them, before the MRI, had an initial mammography and a US with a histopathological biopsy of the primary lesion.
Approximately 60 to 70% of the findings were classified as BI-RADS 2 and BI-RADS 3, while assessing the final US category. The review of the second-look US showed the size of the second malignant additional lesion ranged from 3 to 22 mm, of which 90% were smaller than 10 mm and 66% were smaller than 7 mm.
Most additional malignant lesions, nonpalpable carcinomas, which were previously not detected by mammography and US at first-look diagnosis, were detected by a targeted second-look US examination. These lesions were of category BI-RADS 2 and BI-RADS 3 and smaller than 7 mm.

0 0
 · 
0 Bookmarks
 · 
15 Views
  • Article: Indeterminate or suspicious breast lesions detected initially with MR imaging: value of MRI-directed breast ultrasound.
    [show abstract] [hide abstract]
    ABSTRACT: To retrospectively determine the value of magnetic resonance imaging (MRI)-directed breast ultrasonography (US) in the evaluation of indeterminate or suspicious lesions identified on contrast-enhanced, breast MRI. A total of 395 patients presenting for breast MRI during a 4-year period was retrospectively reviewed. Seventy-one patients were recommended for MRI-directed US for further characterization of indeterminate or suspicious breast lesions detected on MRI. Fifty-five patients (all female; age 31-80 years) had US. Their MRI and US were reviewed and tested for correlations with histologic results or long term follow-up. Logistic regression analyses were used to test for associations between MRI lesion characteristics and US detection rate. US identified 46 of 97 (47%) lesions depicted at MRI from 55 patients (47 [85%] of these patients had histories of breast malignancies). Twelve cancers were found from the 97 lesions (12%). Biopsy was avoidable in 10 lesions (10%). The detection rate with US was slightly higher with "mass" (55% [23/42]) lesions described in MRI than "non-mass" lesions or lymph nodes (42% [23/55]). There was a significant positive association (odd ratio = 1.23: 95% CI = 1.05-1.43, P = .01) between US detection rate and MRI mass lesion size. There was no statistical significance between US detection rate and the presence of malignancies; 42% (5/12) of MRI malignant lesions were not visualized with US. MRI-directed US reduced the number of biopsies required for indeterminate or suspicious MRI lesions. Nevertheless, the lesions which were biopsied had a low rate of malignancy.
    Academic Radiology 06/2008; 15(5):618-25. · 1.69 Impact Factor

Keywords

26 documented additional malignant lesions
 
additional malignant lesions
 
BI-RADS 2
 
BI-RADS 3
 
BI-RADS criteria
 
breast cancer
 
breast carcinoma visualized
 
category BI-RADS 2
 
double-blind retrospective review
 
expert radiologists
 
histopathological biopsy
 
initial mammography
 
lesions
 
magnetic resonance imaging
 
mammography
 
primary lesion
 
second malignant additional lesion
 
successful sonographic correlation
 
targeted second-look
 
ultrasound